State of the Art in therapy of ventilator-associated pneumonia;Aktueller stand der therapie beatmungsassoziierter pneumonien

Intensivmedizin und Notfallmedizin

Volumn 37, Issue 4, 2000, Pages 326-333

  Welte, T ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Antibiotic resistance; Therapy; Ventilator associated pneumonia

Indexed keywords

AMINOPENICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE;

ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTERIUM CONTAMINATION; HUMAN; INFECTIOUS COMPLICATION; PNEUMONIA; REVIEW; VENTILATOR;

EID: 0034046980     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003900050343     Document Type: Review

References (41)

1. Vincent JL, Bihari DJ, Suter PM (1995) The prevalence of nosocomial infections in intensive care units in Europe. JAMA 274:639-644
2. Estes RJ, Meduri GU (1995) The pathogenesis of ventilator-associated pneumonia: mechanisms of bacterial translocation and airway inoculation. Intensive Care Med 21:365-383
3. Nelson S, Mason CM, Kolls J (1995) Pathphysiology of pneumonia. Clin Chest Med 21:365-383
4. Welte T (2000) Prevention of ventilator-associated pneumonia. Monaldi Archives Chest Dis (im Druck)
5. Kappstein I, Schulgen G, Beyer U, Geiger K, Schumacher M, Daschner FD (1992) Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit. Eur J Clin Microbiol Infect Dis 11:504-508
6. George DL, Falk PS, Wunderink RG, Leeper jr KV, Meduri GU, Steere EL, Corbett CE, Mayhall CG (1998) Epidemiology of ventilator acquired pneumonia based on protected bronchoscopic sampling. Am J Respir Crit Care Med 158:1839-1847
7. Luna C, Vujachich P, Niederman MS, Gherardi C, Matera J, Jolly EC (1997) Impact on BAL data on the therapy and outcome of ventilator associated pneumonia. Chest 111:676-687
8. Guillemot D (1999) Antibiotic use in humans and bacterial resistance. Curr Opin Microbiol 2:494-498
9. Cassell GH (1997) Emergent antibiotic resistance: health risks and economic impact. FEMS Immunol Med Microbiol 18:271-274
10. Filutowicz M, Rakowski SA (1998) Regulatory implications of protein assemblies at the gamma origin plasmid R6K - a review. Gene 223:195-204
11. Gold HS, Moellering RC (1996) Antimicrobial-drug resistance. N Engl J Med 335:1445-1453
12. Richardson MD, Kokki MH (1999) New perspectives in the diagnosis of systemic fungal infections. Ann Med 31:327-335
13. Fekety R (1997) Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhoea and colitis. Am J Gastroenterol 92:739-750
14. Fagon JY, Chastre J, Hance AJ, Domart Y. Trouillet JL, Gibert C (1993) Evaluation of clinical judgement in the identification and treatment of nosocomial pneumonia in ventilated patients. Chest 103:547-553
15. Wunderink RG, Woldenberg RS, Zeiss J, Day MD, Ciemens J, Lacher DA (1992) The radiologie diagnosis of autopsy-proved ventilator associated pneumonia. Chest 101:548-558
16. Weite T, Ewig S (1999) Diagnostik von beatmungsassoziierten Pneumonien -wo stehen wir heute? Intensivmedizin 36:224-229
17. Sanchez-Nieto JM, Torres A, Garcia-Cordoba F, El-Ebiary M, Carillo A, Ruiz M, Nunez ML, Niederman MS (1998) Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia. Am J Respir Crit Care Med 157: 371-376
18. Meduri GU, Mauldin GL, Wunderink RG, Leeper KV jr, Jones CB, Tolley E, Mayhall G (1994) Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest 106:221-235
19. Corley DE, Kirtland SH, Winterbauer R, Hammar SP, Dail DH, Bauermeister DE, Bolen JW (1997) Reproducibility of the histologic diagnosis of pneumonia among a panel of four pathologists. Chest 112:458-465
20. Stöve S, Welte T, Wagner TOF, Kola A, Klos A, Bautsch W, Köhl J (1996) Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome. Clin Diagn Lab Immunol 3:175-183
21. Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462-474
22. American Thoracic Society (1995) Hospital acquired pneumonia in adults: diagnosis, assessment of severity, initial anti-microbial therapy, and preventive strategies. Am J Resp Crit Care Med 153: 1711-1725
23. Kollef MH, Vlasnik J, Sharpless L, Pasque C, Murphy D, Fraser V (1997) Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 156:1040-1048
24. Fink MP, Snydman DR, Niederman MS, Leeper KV jr, Johnson RH, Heard SO, Wunderink RG, Caldwell JW, Schentag JJ, Siami GA (1994) Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. Antimicrob Agents Chemother 38:547-557
25. Niederman MS (1994) An approach to empiric therapy of nosocomial pneumonia. Med Clin North Am 78:1123-1141
26. Kirkpatrick CM, Dufull SB, Begg EJ (1999) Pharmacokinetics of gentamycin in 957 patients with varying renal function dosed once daily. Br J Clin Pharmacol 47:637-643
27. McGrath BJ, Marchbanks CR, Gilbert D, Dudley MN (1993) In vitro postantibiotic effect following repeated exposure to imipenem, temafloxacin, and tobramycin. Antimicrob Agents Chemother 37:1723-1725
28. Ewig S, Dalhoff K, Lorenz J, Schaberg T, Welte T, Wilkens H (2000) Empfehlungen zur Therapie und Prophylaxe der nosokomialen Pneumonie. Pneumologie (im Druck)
29. Kresken M, Hafner D (1996) Prävalenz der Antibiotikaresistenz bei klinisch wichtigen Infektionserregern in Mitteleuropa. Chemother J 5:225-230
30. Craig W (1993) Pharmakodynamics of antimicrobial agents as a basis for determing dosage regimens. Eur J Clin Microbiol Infect Dis 12:6-8
31. Schentag JJ, Birmingham MC, Paladino JA, Carr JR, Hyatt JM, Forrest A, Zimmer GS, Adelman MH, Cumbo TJ (1997) In nosocomial pneumonia, otimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance. Semin Respir Infect 12:278-293
32. Hartstein AI, Denny MA, Morthland VI (1995) Control of methicillin-resistant Staphylococcus aureus in a hospital and an intensive care unit. Infect Control Hosp Epidemiol 16:405-411
33. Garner JS, Hospital Infection Control Practices Advisory Comittee (1996) Guidelines for isolation precautions in hospital. Infect Control Hosp Epidemiol 17:53-80
34. Schütte H, Lohmeyer J, Rosseau S, Ziegler S, Siebert C, Kielisch H, Pralle H, Grimminger F, Morr H, Seeger W (1996) Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia, and cardiogenic pulmonary oedema. Eur Respir J 9:1858-1867
35. Stricter RM, Standiford TJ, Huffnagel GB, Colletti LM, Lukacs NW, Kunkel SL (1996) The good, the bad, and the ugly. The role of chemokines in models of human disease. J Immunol 156:3583-3586
36. Bühling F, Thölert G, Kaiser D, Hoffmann B, Reinnold D, Ansorge S, Welte T (1999) Increased release of transforming growth factor (TGF)-beta 1, TGF-bela 2, and chemoattractant mediators in pneumonia. J Interferon Cytokine Res 19:271-278
37. Bühling F, Ittenson A, Kaiser D, Thölert G, Hoffmann B, Reinhold D, Ansorge S, Welte T (2000) MRP8/MRP14, CD11b, and HLA-DR expression of alveolar macrophages in pneumonia. Immunol Letters 71:185-190
38. Karzai W, von Specht BU, Parent C, Haberstroh J, Wollersen K, Natanson C, Banks SM, Eichacker PQ (1999) G-CSF during E. coli versus S. aureus pneumonia in rats has fundamentally different and opposite effects. Am J Respir Crit Care Med 159:1377-1382
39. Nelson S, Belknap SM, Carlson RW, Dale D, deBoisblanc B, Farkas S, Fotheringham N, Ho H, Marrie T, Movahed H, Root R, Wilson J (1998) A randomized controlled trial of filgrastim as an adjunctant to antibiotics for treatment of hospitalized patients with community acquired pneumonia. J Infect Dis 178:1075-1080
40. Mc Kenna PH, Nelson S, Andresen J (1996) Filgrastim (rhuG-CSF) enhances ciprofloxacin uptake and bactericidal activity of human neutrophils in vitro. Am J Resp Crit Care Med 153S:A535
41. Nelson S, Seabury JH (1999) A question of balance. Am J Respir Crit Care Med 159:1365-1367